N M van Besouw
Overview
Explore the profile of N M van Besouw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heidt S, Roelen D, de Vaal Y, Kester M, Eijsink C, Thomas S, et al.
Am J Transplant
. 2012 Mar;
12(6):1469-78.
PMID: 22390272
Quantification of the humoral alloimmune response is generally achieved by measuring serum HLA antibodies, which provides no information about the cells involved in the humoral immune response. Therefore, we have...
2.
Gerrits J, van de Wetering J, van Beelen E, Claas F, Weimar W, van Besouw N
Transplant Proc
. 2009 Jun;
41(5):1577-82.
PMID: 19545683
Immune reactivity after HLA-identical living related (LR) kidney transplantation can be caused by minor histocompatibility antigen and non-HLA antigen mismatches between donor and recipient. In our center, HLA-identical LR kidney...
3.
Gerrits J, Weimar W, van Besouw N
Minerva Urol Nefrol
. 2007 Oct;
59(3):367-72.
PMID: 17912231
During the last decennium, research in the field of organ transplantation changed from studying mechanisms of acute rejection shortly after transplantation to understanding why patients benefit from their grafts only...
4.
Gerrits J, van de Wetering J, Weimar W, van Besouw N
Transplant Proc
. 2006 Nov;
38(9):2825-7.
PMID: 17112840
In the present pilot study, we investigated which proteins are produced after donor stimulation of peripheral blood mononuclear cells from recipients of HLA-identical living related kidney transplant. We used a...
5.
van Besouw N, Zuijderwijk J, Vaessen L, Balk A, Maat A, van der Meide P, et al.
Clin Exp Immunol
. 2005 Jul;
141(3):534-40.
PMID: 16045744
Alloreactive T cells may be activated via a direct or an indirect antigen presentation pathway. We questioned whether the frequency of interferon (IFN)-gamma producing cells determined by enzyme-linked immunospot (ELISPOT)...
6.
van de Wetering J, van der Mast B, de Kuiper P, van Besouw N, Rischen-Vos J, IJzermans J, et al.
Transplant Proc
. 2005 Apr;
37(2):779-81.
PMID: 15848529
Background: Tapering of immunosuppressive medication is indicated to prevent long-term side effects. Recently, we have shown that renal transplant recipients can safely be converted from calcineurin inhibitors to MMF or...
7.
Gerrits J, van de Wetering J, IJzermans J, Weimar W, van Besouw N
Transplant Proc
. 2005 Apr;
37(2):752-4.
PMID: 15848521
A major goal in organ transplantation is to define the optimal immunosuppressive dose. Recently, we demonstrated that the frequency of cytotoxic T lymphocytes (CTLpf) identifies patients in whom the immunosuppressive...
8.
van Besouw N, Balk A, van Vliet M, van der Meide P, Maat A, van Gelder T, et al.
Transplant Proc
. 2002 Nov;
34(7):2942-3.
PMID: 12431667
No abstract available.
9.
van Besouw N, van der Mast B, de Kuiper P, Smak regoor P, Vaessen L, IJzermans J, et al.
Clin Exp Immunol
. 2002 May;
128(2):388-93.
PMID: 11985532
Stable cadaveric renal transplant patients were routinely converted from cyclosporin A (CsA) to either azathioprine (AZA) or mycophenolate mofetil (MMF) 1 year after transplantation to reduce the side effects of...
10.
van der Mast B, van Besouw N, de Kuiper P, Vaessen L, Gregoor P, Ijzermans J, et al.
Transplantation
. 2001 Sep;
72(5):873-80.
PMID: 11571453
Background: A reliable immunological assay for quantification of donor-specific alloreactivity to identify patients at risk for future allograft rejection would be a helpful tool in organ transplantation. Therefore, we questioned...